[Molecular targeted treatment of hematological diseases with monoclonal antibodies and tyrosine kinase inhibitors. The Danish Society of Hematology].
Geisler
Christian Hartmann
CH
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D003718:Denmark; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D012955:Societies, Medical
D000911:Antibodies, Monoclonal; D004791:Enzyme Inhibitors; D011505:Protein-Tyrosine Kinases
Molekylaer målrettet behandling af haematologiske sygdomme med monoklonale antistoffer og tyrosinkinasehaemmere. Dansk Haematologisk Selskab.